financetom
Business
financetom
/
Business
/
Exponent Fiscal Q2 Earning, Revenue Rise; Sees Flat Q3 Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exponent Fiscal Q2 Earning, Revenue Rise; Sees Flat Q3 Revenue
Jul 25, 2024 3:00 PM

05:39 PM EDT, 07/25/2024 (MT Newswires) -- Exponent (EXPO) reported Q2 earnings late Thursday of $0.57 per diluted share, up from $0.50 a year earlier.

Three analysts polled by Capital IQ expected $0.50.

Revenue before reimbursements for the quarter ended June 28 was $132.4 million, compared with $129.7 million a year earlier. Three analysts surveyed by Capital IQ expected $130.8 million.

For Q3, the company said it expects revenue before reimbursements to be roughly flat. Three analysts surveyed by Capital IQ expect $123.6 million.

For full-year 2024, revenue before reimbursements is expected to grow in the low to mid-single digits. Previously, it expected growth in the low-single digits. Three analysts surveyed by Capital IQ expected $509.4 million.

The company maintained its quarterly cash dividend of $0.28 per share, payable Sept. 20 to shareholders of record on Sept. 6.

Price: 106.21, Change: +0.14, Percent Change: +0.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rocket Doctor AI Closes $4.2 Million Private Placement
Rocket Doctor AI Closes $4.2 Million Private Placement
Aug 22, 2025
09:00 AM EDT, 08/22/2025 (MT Newswires) -- Rocket Doctor AI ( TREIF ) , formerly called Treatment.com AI, said Friday that it raised $4.2 million after closing its private placement of special warrants and units. The company issued 3,677,400 special warrants priced at $0.50 each for $1.8 million in proceeds, and 4,792,000 units at $0.50 apiece for $2.4 million in...
Biohaven Says US FDA Deems Advisory Committee Meeting No Longer Needed on Troriluzole
Biohaven Says US FDA Deems Advisory Committee Meeting No Longer Needed on Troriluzole
Aug 22, 2025
09:25 AM EDT, 08/22/2025 (MT Newswires) -- Biohaven ( BHVN ) said in a filing late Thursday that it was informed by the US Food and Drug Administration that an advisory committee meeting is no longer needed on the company's new drug application for troriluzole to treat adults with spinocerebellar ataxia. The company said the FDA's decision on the application...
European farmers facing higher costs after EU tariffs on Russian fertiliser imports
European farmers facing higher costs after EU tariffs on Russian fertiliser imports
Aug 22, 2025
LONDON (Reuters) -EU tariffs on Russian fertiliser imports that aim to cut funding for Moscow's war in Ukraine have so far hit European farmers, raising costs and risking higher consumer prices while Russian companies say they can divert exports to other markets. We're shooting ourselves in the foot, farmer Cedric Benoist, deputy secretary general of French wheat farmers union AGPB...
Cracker Barrel Old Country Store Shares Slightly Recover Pre-Bell After New Logo Unveiled
Cracker Barrel Old Country Store Shares Slightly Recover Pre-Bell After New Logo Unveiled
Aug 22, 2025
09:24 AM EDT, 08/22/2025 (MT Newswires) -- Cracker Barrel Old Country Store ( CBRL ) shares were up about 1% in recent Friday premarket activity, recovering from a 7.2% drop on Thursday after the restaurant chain introduced its new logo. On Tuesday, the company said its new logo is now rooted even more closely to the iconic barrel shape, adding...
Copyright 2023-2026 - www.financetom.com All Rights Reserved